Optimum Investment Advisors Buys 400 Shares of DocuSign, Inc. (NASDAQ:DOCU)

Optimum Investment Advisors boosted its stake in shares of DocuSign, Inc. (NASDAQ:DOCU) by 200.0% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 600 shares of the company’s stock after acquiring an additional 400 shares during the period. Optimum Investment Advisors’ holdings in DocuSign were worth $54,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently added to or reduced their stakes in DOCU. Natixis Advisors LLC bought a new position in DocuSign during the 3rd quarter worth $873,000. Caprock Group LLC acquired a new stake in shares of DocuSign in the 3rd quarter valued at $319,000. B. Metzler seel. Sohn & Co. Holding AG acquired a new stake in shares of DocuSign in the 3rd quarter valued at $312,000. Commerce Bank boosted its holdings in shares of DocuSign by 3.6% in the 3rd quarter. Commerce Bank now owns 9,852 shares of the company’s stock valued at $612,000 after purchasing an additional 341 shares in the last quarter. Finally, Massachusetts Financial Services Co. MA boosted its holdings in shares of DocuSign by 1.4% in the 3rd quarter. Massachusetts Financial Services Co. MA now owns 32,391 shares of the company’s stock valued at $2,011,000 after purchasing an additional 447 shares in the last quarter. Institutional investors own 77.64% of the company’s stock.

Insider Transactions at DocuSign

In other news, insider James P. Shaughnessy sold 7,500 shares of DocuSign stock in a transaction dated Thursday, January 2nd. The stock was sold at an average price of $90.17, for a total value of $676,275.00. Following the completion of the transaction, the insider now directly owns 43,781 shares of the company’s stock, valued at approximately $3,947,732.77. This trade represents a 14.63 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Teresa Briggs sold 534 shares of DocuSign stock in a transaction dated Monday, March 17th. The stock was sold at an average price of $87.41, for a total value of $46,676.94. Following the completion of the transaction, the director now directly owns 8,270 shares of the company’s stock, valued at approximately $722,880.70. This trade represents a 6.07 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 97,851 shares of company stock valued at $8,579,369. Corporate insiders own 1.66% of the company’s stock.

Analyst Upgrades and Downgrades

A number of brokerages have weighed in on DOCU. Morgan Stanley raised their target price on DocuSign from $62.00 to $97.00 and gave the company an “equal weight” rating in a report on Friday, December 6th. HSBC reaffirmed a “reduce” rating on shares of DocuSign in a report on Friday, December 6th. JMP Securities reissued a “market outperform” rating and set a $124.00 price objective on shares of DocuSign in a report on Tuesday, January 7th. Needham & Company LLC reissued a “hold” rating on shares of DocuSign in a report on Friday, March 14th. Finally, Wedbush reissued a “neutral” rating and set a $100.00 price objective on shares of DocuSign in a report on Friday, March 14th. Two equities research analysts have rated the stock with a sell rating, nine have given a hold rating and four have issued a buy rating to the company. According to data from MarketBeat.com, DocuSign currently has a consensus rating of “Hold” and an average price target of $95.00.

DocuSign Trading Up 3.5 %

Shares of DOCU opened at $88.06 on Monday. The company has a market capitalization of $17.79 billion, a PE ratio of 18.16, a PEG ratio of 6.94 and a beta of 1.02. DocuSign, Inc. has a 12 month low of $48.70 and a 12 month high of $107.86. The stock’s 50-day moving average price is $87.54 and its two-hundred day moving average price is $80.47.

DocuSign (NASDAQ:DOCU) last announced its earnings results on Thursday, March 13th. The company reported $0.86 EPS for the quarter, topping the consensus estimate of $0.84 by $0.02. The firm had revenue of $776.25 million for the quarter, compared to the consensus estimate of $760.94 million. DocuSign had a return on equity of 14.90% and a net margin of 34.73%. The business’s quarterly revenue was up 9.0% compared to the same quarter last year. During the same period in the previous year, the business earned $0.76 EPS. Equities research analysts predict that DocuSign, Inc. will post 1.17 EPS for the current fiscal year.

DocuSign Profile

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.